GGrantIndex
← Leaderboards

Jordan J Tang

Oklahoma Medical Research Foundation

$8,081,921
Attributed
$8,081,921
Total exposure
4
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $951.2K · FY200511
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11

Funding mix

By agency

NIH$8,081,921 · 4

By mechanism

R01$5,895,009 · 2
U19$2,179,734 · 1
P41$7,178 · 1

Top collaborators

No co-investigators on record.

Most similar at Oklahoma Medical Research Foundation

Same institution · by research overlap

Others in their field

Top investigators on “Endopeptidases

Research focus

EndopeptidasesX Ray CrystallographyProtease InhibitorProteinsStructureInhibitor/AntagonistPeptide HydrolasesEnzyme ComplexBinding (Molecular Function)Toxic EffectPropertySmall MoleculeDesignLaboratory MouseCellsBlood - Brain Barrier AnatomyCathepsinsDrug Design /Synthesis /ProductionCleaved CellAlzheimer&AposBlood Brain BarrierDrug Screening /EvaluationBeta-Site App Cleaving Enzyme 1Amyloid Beta-Protein Precursor

Grant awards (20)

Beta Secretase Inhibition for Treating Alzheimer's Disease$206,330
R01 · FY2011 · AG · contact PI
Beta Secretase Inhibition for Treating Alzheimer's Disease$495,902
R01 · FY2010 · AG · contact PI
Beta Secretase Inhibition for Treating Alzheimer's Disease$479,615
R01 · FY2009 · AG · contact PI
Beta Secretase Inhibition for Treating Alzheimer's Disease$466,591
R01 · FY2008 · AG · contact PI
Therapeutic Interventions Targeted on Anthrax Toxins$453,046
U19 · FY2008 · AI · contact PI
Beta Secretase Inhibition for Treating Alzheimer's Disease$456,011
R01 · FY2007 · AG · contact PI
Therapeutic Interventions Targeted on Anthrax Toxins$306,928
U19 · FY2007 · AI · contact PI
Therapeutic Interventions Targeted on Anthrax Toxins$470,912
U19 · FY2006 · AI · contact PI
Beta Secretase Inhibition for Treating Alzheimer's Disease$470,461
R01 · FY2006 · AG · contact PI
SECRETASE INHIBITORS FOR TREATING ALZHEIMER'S DISEASE$480,268
R01 · FY2005 · AG
Therapeutic Interventions Targeted on Anthrax Toxins$470,894
U19 · FY2005 · AI
Therapeutic Interventions Targeted on Anthrax Toxins$477,954
U19 · FY2004 · AI
SECRETASE INHIBITORS FOR TREATING ALZHEIMER'S DISEASE$468,407
R01 · FY2004 · AG
CRYSTAL STRUCTURE OF BETA-SECRETASEBOUND TO INHIBITORS$7,178
P41 · FY2004 · RR
SECRETASE INHIBITORS FOR TREATING ALZHEIMER'S DISEASE$454,992
R01 · FY2003 · AG
SECRETASE INHIBITORS FOR TREATING ALZHEIMER'S DISEASE$441,740
R01 · FY2002 · AG
MUTATIONS EFFECTS ON INHIBITION OF HIV PROTEASE$356,991
R01 · FY2002 · AI
SECRETASE INHIBITORS FOR TREATING ALZHEIMER'S DISEASE$434,612
R01 · FY2001 · AG
MUTATIONS EFFECTS ON INHIBITION OF HIV PROTEASE$346,592
R01 · FY2001 · AI
MUTATIONS EFFECTS ON INHIBITION OF HIV PROTEASE$336,497
R01 · FY2000 · AI